Junming Yie

This inventor holds 8 USPTO granted patents and 7 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Amgen Inc., Agouron Pharmaceuticals, Inc., Amgen Fremont Inc.. Active years: 2010-2025.

USPTO Granted Patents = 8 (Patent Applications = 7)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 3)

EPO Patents = 2 (Patent Applications = 9)

Average Co-Inventor Count = 9.9

ph-index = 4

Forward Citations = 89(Granted Patents)

Location History:

Thousand Oaks, CA (US) (2010 - 2017)
Warren, NJ (US) (2019 - 2024)

Company Filing History:

Agouron Pharmaceuticals, Inc.

where one patent can have more than one assignee

Years Active: 2010-2025

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12252540 - Nucleic acid molecules encoding binding proteins for gastric inhibitory peptide receptor (GIPR) (2025-03-18),

2. 12214051 - Method of treating or ameliorating metabolic disorders using GLP-1 receptor agonists conjugated to antagonists for gastric inhibitory peptide receptor (GIPR) (2025-02-04),

3. 11248052 - Antigen binding proteins that bind to a complex comprising β-Klotho and an FGF receptor (2022-02-15),

4. 11046774 - Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (GIPR) in combination with GLP-1 agonists (2021-06-29),

5. 10905772 - Method of treating or ameliorating metabolic disorders using GLP-1 receptor agonists conjugated to antagonists for gastric inhibitory peptide receptor (GIPR) (2021-02-02),

6. 10294303 - Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (GIPR) in combination with GLP-1 agonists (2019-05-21),

7. 9574002 - Human antigen binding proteins that bind to a complex comprising β-Klotho and an FGF receptor (2017-02-21),

8. 7807159 - Antibodies to myostatin (2010-10-05),

I specialize in writing content related to innovations, inventions, inventors, patent attorneys, assignees, and patents.

Profile summary based on public USPTO records.